Article

Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

2022-09-22

Abstract excerpt

Measurable residual disease (MRD), defined as the population of cancer cells which persists following therapy, serves as the critical reservoir for disease relapse in acute myeloid leukemia (AML) and other malignancies. Understanding the biology enabling MRD clones to resist therapy is necessary to guide the development of more effective curative treatments. Discriminating between residual leukemic clones, preleuk...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b8145b98-1e8b-5e12-b018-fbfb3a1c85bd
DOI: 10.1101/2022.09.20.508786

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemiaDOI 10.1101/2022.09.20.508786Read

Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.Semantic proximity Read

Single-cell mutational profiling enhances the clinical evaluation of AML MRD.Semantic proximity Read

Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual DiseaseSemantic proximity Read

Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid LeukemiaSemantic proximity Read

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development.Semantic proximity Read

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaSemantic proximity Read

Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse.Semantic proximity Read

Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistanceSemantic proximity Read

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemiaSemantic proximity Read

Next‐generation sequencing for measurable residual disease detection in acute myeloid leukaemiaSemantic proximity Read

Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML)Semantic proximity Read

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.Semantic proximity Read